论文部分内容阅读
方示:門診治療,采用“變重盲目”檢查制度。 對象:男9,女7名高血壓患者,年龄32-55歲,血壓不低於160/100,大部分患者血壓大於200/100,未治療前都進行詳細的檢查,包括小便細菌培養,分泌性腎盂造影,酚紅試驗,及靜脈注射5 c.c. 以排除嗜(?)細胞瘤。所有患者都有因高血壓所致之器官性改變如氮瀦留、乳頭水腫及嚴種之心力衰竭。 治療葯物及方法:将病人分成四組:(1)安慰劑組;(2)魯米那組;(3)利血平組;(4)利血平加用Hydralazine。共觀察32星期,用降血壓葯物者,最初八星期用安慰劑,中間16星期用降壓葯物,最後八星期又用安慰劑。四組患者都有相同之血壓及社會環境。葯物外面只標以甲乙丙丁。血壓由一名專
Fang said: out-patient treatment, the use of “blind change” system of inspection. Subjects: male 9, female 7 hypertensive patients, aged 32-55 years, blood pressure of not less than 160/100, most patients with blood pressure greater than 200/100, were not examined before treatment, including urinary bacterial culture, secretion Pyelography, phenol red test, and intravenous injection of 5 cc to exclude neoplasia. All patients had organ changes due to high blood pressure such as nitrogen retention, papillary edema, and severe heart failure. Therapeutic drugs and methods: The patients were divided into four groups: (1) placebo group; (2) luminal group; (3) reserpine group; (4) reserpine plus Hydralazine. A total of 32 weeks of treatment with antihypertensive drugs was given in the first eight weeks with placebo and in the middle with antihypertensive drugs for 16 weeks and with placebo in the last eight weeks. Four groups of patients have the same blood pressure and social environment. The drug is only marked with methyl ethyl propyl Ding. Blood pressure by a specialist